AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06056245 — intervention group
Intervention type: DRUG
Intervention: Post-operative
Description: Installation of IV-PCA of methadone. Program to be used with no background infusion, boluses of 1 mg, and the intervals between boluses of 8 minutes.
Study NCT04786587 — intervention group
Intervention type: OTHER
Intervention: self-administered questionnaire
Description: Each pregnant woman completes the self-report during her prenatal consultation and will have a unique blood sampling for dosage of phosphatidylethanol after she returned her self-report to the practitioner and if she is included in the study (informed consent given).~A self-report, including the T-ACE, is the usual prenatal consultation procedure in the three maternities of the study. The specific procedure for the study is to perform a blood test for dosage of phosphatidylethanol in eligible pregnant women after informed consent.
Study NCT05174910 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Obsidian ASG
Description: Application of an autologous platelet-rich fibrin matrix
Study NCT05542927 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: urine chloride
Description: Serum chloride, urinary chloride \& serum creatinine will be requested on the first day of admission in Intensive Care Unit (ICU). 2. Serum chloride \& urinary chloride will be requested every 48 hours in ICU with correlation between urinary chloride concentrations, AKI \& mortality. 3. Serum creatinine will be requested every 24 hours in ICU. 4. Monitoring of Urinary Output (U.O.P.) every 24 hours
Study NCT06005922 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: physiotherapy
Description: ultrasound hotpack electrotherapy joint range of motion exercises isometric neck exercises stretching exercises
Study NCT06005922 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: physiotherapy
Description: ultrasound hotpack electrotherapy joint range of motion exercises isometric neck exercises stretching exercises
Study NCT06005922 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TMJ exercises
Description: tongue relaxation position TMJ isometric strengthening exercises Posture exercises Isometric neck extension in neutral position back extension Strengthening the abdominal muscles Supine dorsal stretch pectoral stretch
Study NCT06002516 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: RELIEF-pathway
Description: The personalized web-based education tool contains information on:~* Information of cause and symptoms of functional dyspepsia, irritable bowel syndrome and uncomplicated symptomatic cholecystolithiasis;~* Symptom checker based on the ROME III and ROME IV criteria;~* Red flags symptoms defined as direct or indirect signs of upper GI hemorrhage.~* Lifestyle adjustments to improve abdominal symptoms and quality of life.~* Information on effect of upper gastrointestinal endoscopy, colonoscopy and laparoscopic cholecystectomy.~After the web-based education tool is completed we will offer an additional visit at the Prevention and Lifestyle clinic, this is optional and not obligatory.
Study NCT04798716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8)
Description: Escalating dose 2 X 10\^9, 4 X 10\^9, 8 X 10\^9/mL
Study NCT04798716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MSC-exosomes delivered intravenously every other day on an escalating dose (8:4:8)
Description: Escalating dose 8 X 10\^9, 4 X 10\^9, 8 X 10\^9 mL
Study NCT04798716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MSC-exosomes delivered intravenously every other day (8:8:8)
Description: Dosed 8 X 10\^9, 8 X 10\^9, 8 X 10\^9 mL
Study NCT04798716 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: MSC-exosomes delivered intravenously every other day (8:8:8)
Description: Dosed 8 X 10\^9, 8 X 10\^9, 8 X 10\^9 mL
Study NCT06238206 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Focus group discussion
Description: The participant will be asked to take part in three separate focus group discussions implementing the co-design principle. Following the co-design principle the participants will actively contribute towards the primary outcomes. Open questions will be asked to guide the discussion. Interaction between participants will be encouraged.
Study NCT04913662 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pressurized Intraperitoneal Aerosol Chemotherapy
Description: Aerosolization of chemotherapic agent for intraperitoneal chemotherapy
Study NCT04660396 — intervention group
Intervention type: DEVICE
Intervention: BVA-100
Description: The BVA-100 is a software package designed to calculate human blood volume using the method of tracer dilution. It uses tagged serum albumin (a commonly used tag is 131I, resulting in 131I -HSA). Data inputs to the software come from the measured characteristics of subject blood samples (hematocrit and tracer concentration) and tracer calibration standards. The package also calculates the subject expected (or ideal) blood volume from physical parameters. Hyper- or hypovolemia, associated red blood cell volumes, and transudation rate are reported, with statistics showing the quality of the results. The subject blood samples and calibration standards are measured in a gamma counter, whose output is automatically, or manually, input to this calculation program.
Study NCT05160129 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Selective focal stimulation of ALIC-pathways
Description: DBS will be applied selectively to different electrode contacts/ segments to evaluate clinical, behavioral, and electrocortical responses of specific pathways within the ALIC.
Study NCT05270798 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: triiodothyronine
Description: Patients in septic shock who meet the diagnostic criteria for euthyroid sick syndrome will be divided into two groups; patients with low T3 levels and patients with low T3 and T4 levels. Both of these groups will be further randomly divided into patients receiving T3 hormone and patients receiving placebo.
Study NCT05270798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: triiodothyronine
Description: Patients in septic shock who meet the diagnostic criteria for euthyroid sick syndrome will be divided into two groups; patients with low T3 levels and patients with low T3 and T4 levels. Both of these groups will be further randomly divided into patients receiving T3 hormone and patients receiving placebo.
Study NCT05693792 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: No treatment regimen will be deployed in this follow-up study.
Study NCT05009251 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reminder
Description: Mailed letter, short message service (SMS) text, and/or patient portal message
Study NCT05009251 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Risk reduction
Description: Mailed letter, SMS, and/or patient portal message
Study NCT05009251 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Medical records-based recommendation
Description: Mailed letter, SMS, and/or patient portal message
Study NCT05009251 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Algorithm-based recommendation
Description: Mailed letter, SMS, and/or patient portal message
Study NCT05284604 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mesenchymal Stem Cells (MSCs)
Description: The MSCs are recovered from bone marrows of healthy donors. Each donor is carefully screened for pathogens to assure the product is safe. The MSCs are strictly compliant with FDA standards under Current Good Manufacturing Practice (cGMP) regulations.
Study NCT05284604 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Mesenchymal Stem Cells (MSCs)
Description: The MSCs are recovered from bone marrows of healthy donors. Each donor is carefully screened for pathogens to assure the product is safe. The MSCs are strictly compliant with FDA standards under Current Good Manufacturing Practice (cGMP) regulations.
Study NCT05535452 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Photobiomodulation through LED board
Description: The applications will be performed within 1 hour after radiotherapy, three times a week, by a trained team, consisting of physiotherapists and physiotherapy students, through the sportllux LED plate equipment, medium size, which combines light emitters in two wavelengths: red (660nm) and infrared (850nm).
Study NCT05535452 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Photobiomodulation through LED board
Description: The applications will be performed within 1 hour after radiotherapy, three times a week, by a trained team, consisting of physiotherapists and physiotherapy students, through the sportllux LED plate equipment, medium size, which combines light emitters in two wavelengths: red (660nm) and infrared (850nm).
Study NCT05072483 — intervention group
Intervention type: DEVICE
Intervention: MRI
Description: Research pulse sequences.
Study NCT04442763 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Densah Burs
Description: osseodensification method
Study NCT04442763 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard drills
Description: conventional drilling
Study NCT05331144 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
Description: Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine) will be used to treat high blood pressure. Additional antihypertensive medications may be used if needed.
Study NCT05331144 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PCP
Description: Participants will follow their PCP's recommendations for BP control.
Study NCT04897763 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 89Zr-TLX250 PET/CT
Description: Pretherapeutic 89Zr-TLX250 PET/CT
Study NCT05423171 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensive bimanual therapy
Description: 60-hour intensive therapy promoting the use of both hands (ex: bimanual activities, games,...)
Study NCT06036576 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levothyroxine Pill
Description: all participants will receive levothyroxine treatment of 1.6 micrograms per kg per day early in the morning on empty stomach.
Study NCT06258876 — intervention group
Intervention type: OTHER
Intervention: PrEP in general practice
Description: Prescription and follow-up of PrEP in general practice
Study NCT06051188 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flow-controlled ventilation
Description: Flow-controlled ventilation (FCV)
Study NCT06186037 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination drug group of Ezetimibe 10 mg/Rosuvastatin 5 mg
Description: Oral administration once a day, taking it for 3 years
Study NCT06186037 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mono drug group of Rosuvastatin 20 mg
Description: Oral administration once a day, taking it for 3 years
Study NCT05503225 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colchicine 0.5 MG
Description: 0.5mg Orally Taken Colchicine
Study NCT04878913 — intervention group
Intervention type: DRUG
Intervention: C21
Description: C21 was administered in the VP-C21-006 trial
Study NCT04878913 — intervention group
Intervention type: DRUG
Intervention: Placebo
Description: Placebo was administered in the VP-C21-006 trial
Study NCT04773236 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sodium bicarbonate 8.4%
Description: mixing the sodium bicarbonate with 2%lidocaine and 1:80.000 epinphrine using mixing pen (onset buffering system)
Study NCT04773236 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 2%lidocaine with 1:80.000 epinphrine
Description: injection
Study NCT04773236 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Mixing pen (onset buffering system)
Description: Premixing of the two solutions sodium bicarbonate and lidocaine with epinphrine before the local anesthesia adminstration to the patient
Study NCT06014099 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Long peripheral venous catheters for blood collection
Description: used LPC for blood collection
Study NCT06014099 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Midline catheter for blood collection
Description: used MCs for blood collection
Study NCT06014099 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: SPCs for blood collection
Description: used SPCs for blood collection
Study NCT06583408 — intervention group
Intervention type: OTHER
Intervention: Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24)
Description: Subjects will complete the ASA food diary for 2 weekdays and 1 weekend day
Study NCT06583408 — intervention group
Intervention type: OTHER
Intervention: REVEAL Questionnaire
Description: Subjects will complete the REVEAL questionnaire form. This form includes questions about current and past medical history, including reproductive history, lifestyle specifics, and assessment of current health status.
Study NCT06583577 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3D Ostomy simulator
Description: The ostomy simulator is 3D printed model created in collaboration with Earl E. Bakken Medical Devices Center at the University of Minnesota. The anatomically accurate model is created by analyzing de-identified segmental imaging after bowel diversion surgeries. The Stratasys J750 Polyjet 3D Printer is utilized to create the simulator using usual synthetic material.
Study NCT06584162 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vedolizumab Injection
Description: Based on therapeutic drug monitoring, patients could be de-escalated based on a pharmacokinetic model:~Dosing interval Trough Target 20 mg/L~Adjust dosing interval to:~2 weeks \< 33 mg/L 2 weeks 2 weeks 33 - 46 mg/L 3 weeks 2 weeks ≥ 46 mg/L 4 weeks 3 weeks \< 20 mg/L 2 weeks 3 weeks 20 - 29 mg/L 3 weeks 3 weeks ≥ 29 mg/L 4 weeks 4 weeks \< 13 mg/L 2 weeks 4 weeks 13 - 20 mg/L 3 weeks Version number: 6.1, 24-06-2024 22 of 44 4 weeks ≥ 20 mg/L 4 week
Study NCT05455931 — intervention group
Intervention type: DRUG
Intervention: Poteligeo
Description: Poteligeo treatment will be used as prescribed by the Investigator in accordance with the terms of the reimbursed indication within the relevant country. The assignment of the patient to a particular therapeutic strategy falls within current practice and the prescription of Poteligeo is clearly separated from the decision to include the patient in the study.
Study NCT06548932 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GZR33 Injection
Description: A single dose
Study NCT06548932 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GZR101 Injection
Description: A single dose
Study NCT06548932 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: A single dose
Study NCT06429774 — intervention group
Intervention type: OTHER
Intervention: Neurological function
Description: Neurological function will be examined using Glasgow Coma Scale (GCS) and Extended Glasgow Outcome Scale (GOSE).The GOSE was created as an advancement from the original GOS. The GOSE score categorizes the prognosis of patients with traumatic brain injury into eight categories.The 8 categories are: Dead, Vegetative State, Lower Severe Disability, Upper Severe Disability, Lower Moderate Disability, Upper Moderate Disability, Lower Good Recovery, and Upper Good Recovery.
Study NCT06429774 — intervention group
Intervention type: OTHER
Intervention: Mental State, cognitive function, and life quality assessment
Description: Mental State, cognitive function, and life quality will be examined using the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9(PHQ-9), Rivermead post-concussion symptoms questionnaire(RPQ), PTSD Checklist-5 Version(PCL-5)，Six-Item Screener（SIS） and 12-Item Short-Form Health Survey version 2(SF-12v2).
Study NCT06429774 — intervention group
Intervention type: OTHER
Intervention: Peripheral blood test
Description: Collect peripheral blood samples from patients.
Study NCT06429774 — intervention group
Intervention type: OTHER
Intervention: Hematoma test
Description: Collect hematoma fluid, dura mater, and hematoma outer membrane samples from patients.
Study NCT05860465 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPH4336 Tablets
Description: SPH4336 Tablets ：Administered by oral; Letrozole tablets：Administered by oral; Fulvestrant injection：Administered by intravenous infusion
Study NCT05860465 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SPH4336 Tablets Placebo
Description: SPH4336 Tablets Placebo ：Administered by oral; Letrozole tablets：Administered by oral; Fulvestrant injection：Administered by intravenous infusion
Study NCT05460468 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: Transcranial magnetic stimulation (TMS) is a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve a variety of cognitive conditions, and to probe the dynamics of normal brain function.
Study NCT05138679 — intervention group
Intervention type: PROCEDURE
Intervention: Revascularization
Description: Endovascular or surgical restoration of arterial blood flow.
Study NCT05138679 — intervention group
Intervention type: PROCEDURE
Intervention: Primary major amputation
Description: Primary below- or above knee major amputation without prior revascularization.
Study NCT05138679 — intervention group
Intervention type: OTHER
Intervention: Best medical treatment
Description: Conservative treatment of acute lower limb ischemia - without prior revascularization.
Study NCT05460468 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Magnetic Stimulation
Description: Transcranial magnetic stimulation (TMS) is a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve a variety of cognitive conditions, and to probe the dynamics of normal brain function.
Study NCT05098145 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FCR001
Description: Enriched hematopoietic stem cell infusion
Study NCT06576219 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group Music Therapy
Description: My Life Is Music group therapy model
Study NCT04828005 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nalmefene hydrochloride
Description: 3mg Nasal spray
Study NCT04828005 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Naloxone hydrochloride
Description: 4mg Nasal Spray
Study NCT05207683 — intervention group
Intervention type: OTHER
Intervention: echocardiography
Description: All the patients will be subjected to thorough medical history and clinical examination and the results of the previous investigations will be collected aiming for reaching the diagnosis of the etiology of pulmonary hypertension. ct pulmonary angiography and then right heart catheterization will be done in case of undiagnosed etiology.
Study NCT04684953 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Throid autotransplantation
Description: Operative
Study NCT04684953 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Hormone
Description: thyroid hormone replacement therapy
Study NCT05215158 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: to compare perineural (peribulbar) dexmedetomidine versus intravenous (I.V.) dexmedetomidine when used as an adjuvant with local anesthesia in adult strabismus surgery.
Study NCT05729984 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Paula exercises
Description: The patients will perform Paula exercises after the cesarean delivery
Study NCT04937127 — intervention group
Intervention type: BEHAVIORAL
Intervention: I-LEARN training
Description: Training of psycho-behavorial disorders care in neurodegenerative diseases: including a theoretical part in e-learning and a practical part
Study NCT04937127 — intervention group
Intervention type: OTHER
Intervention: usual care
Description: usual care
Study NCT05899127 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine
Description: 1.5mg/kg induction，1.5 mg/kg/h maintenance
Study NCT05899127 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9%NaCl
Description: 2mg/kg induction，1.5 mg/kg/h maintenance
Study NCT05729984 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Gum chewing
Description: The patients will be given chewing gum and will be asked to chew it after the cesarean delivery
Study NCT04969731 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Immuncell-LC
Description: IV
Study NCT04969731 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Description: IV
Study NCT04969731 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: IV
Study NCT06178003 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tpdelansbsalbac
Description: Tpdelansbsalbac,which is Knockdown of ansB, a gene that expresses L-mentholase secreted into the extracellular region, on the basis of the genetic background of bacterium VNP20009, and construction of an ansB gene-deficient mutant strain, ΔansB.
Study NCT06221722 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: BOLD-fMRI
Description: Blood-Oxygen-Level Dependent Functional Magnetic Resonance Imaging
Study NCT06221722 — intervention group
Intervention type: DRUG
Intervention: Regular treatment of functional constipation
Description: at least 3 months of continuous regular treatment. This treatment included the utilization of osmotic laxatives, stimulant laxatives, prosecretory agents, and a high-fibre diet.
Study NCT06221722 — intervention group
Intervention type: DRUG
Intervention: fluoxetine
Description: Fluoxetine oral treatment for 4 weeks.